Arena Pharmaceuticals, Inc. (ARNA) Social Stream
Arena Pharmaceuticals Inc (ARNA) Price Targets From Analysts
Use the tables below to see what analysts covering Arena Pharmaceuticals Inc think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-15 | 6 | $120 | $80 | $97.428 | $99.99 | -2.56% |
| 2021-12-08 | 7 | $120 | $71 | $94.125 | $99.99 | -5.87% |
| 2021-12-14 | 10 | $120 | $71 | $95.428 | $99.99 | -4.56% |
| 2021-12-21 | 10 | $120 | $71 | $96.375 | $99.99 | -3.62% |
| 2022-02-24 | 10 | $100 | $71 | $93.875 | $99.99 | -6.12% |
The Trend in the Analyst Price Target
ARNA's average price target has moved down $3.36 over the prior 44 weeks.
ARNA reports an average of 48.6% for its upside potential over the past 49 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-05-22 | 15 | 120 | 76 | 97.530 | 62.79 | 55.33% |
| 2021-08-01 | 15 | 120 | 76 | 97.530 | 61.86 | 57.66% |
| 2021-09-19 | 15 | 120 | 76 | 95.250 | 61.05 | 56.02% |
| 2021-09-20 | 15 | 120 | 76 | 95.250 | 59.86 | 59.12% |
| 2021-12-08 | 6 | 120 | 71 | 94.125 | 54.71 | 72.04% |
ARNA Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 2.6 | 2 | 0 | 8 | 0 | 0 | 10 |
The Trend in the Broker Recommendations
ARNA's average broker recommendation rating worsened by 1.6 over the prior 21 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In terms of how Arena Pharmaceuticals Inc fares relative to all US stocks, note that its upside potential (average analyst target price relative to current price) is higher than 51.39% of that group.
- Arena Pharmaceuticals Inc's average analyst price target is greater than 674.15% of Pharmaceutical Products stocks.
- In terms of how Arena Pharmaceuticals Inc fares relative to stocks in the mid market cap category, note that its number of analysts covering the stock is greater than 490.76% of that group.
- ARNA has a lower variance in analysts' estimates than -395.72% of stocks in the mid market cap category.
In the Pharmaceutical Products industry, APLS, ANAB, and AMTI are the three stocks most similar to Arena Pharmaceuticals Inc regarding the price target and analyst recommendation information presented here.
Make investment decisions regarding ARNA using the data that counts. Try POWR Ratings for free.